Abstract
This study tested the hypothesis that people using pre-exposure prophylaxis (PrEP) would be more likely to report condomless anal sex than those not taking PrEP. Data were from an ongoing study conducted with a cohort of Black and Latino young men who have sex with men (YMSM) recruited in Los Angeles (CA, USA). Of the 399 YMSM in the sample, 14% were currently using PrEP. Using three different measures of condom use, across two different recall periods all except one test result supported an inverse relationship between PrEP and condom use for anal sex. Tests of a risk index provided further significant findings supporting this hypothesis.
Additional keywords: condom displacement, public health, sexually transmissible infections
Introduction
Although pre-exposure prophylaxis (PrEP) is now the mainstay of HIV prevention,1,2 recent and unprecedented rates of sexually transmissible infections (STIs) continue to raise the possible occurrence of condom displacement (i.e. abandoning condom use in lieu of the protection from PrEP).3–6 This occurrence may be especially problematic in populations of high STI prevalence, thus making even occasional lapses in condom use opportune for transmitting chlamydia, gonorrhoea and syphilis. In the US, only scant evidence exists relative to whether condom displacement may occur.7,8 Studies have yet to focus specifically on the population most at risk of HIV and STIs, namely young men of colour who have sex with men.2 Accordingly, within that population, this study tested the hypothesis that people using PrEP would be more likely to report condomless anal sex than those not taking PrEP.
Methods
Data were from an ongoing study conducted with a cohort of Black and Latino young men who have sex with men (YMSM) recruited in Los Angeles, California (USA). Eligibility criteria were age 16–24 years, male sex at birth, self-identified as gay, bisexual or uncertain, reporting sex with males in the previous 12 months and Black/African American, Latino or multiethnic/ racial. The Children’s Hospital Los Angeles’ Institutional Review Board approved the study protocol. For this secondary analysis, 399 in the cohort were HIV negative and served as the subsample.
To optimally test the hypothesis, four measures were used. Three were binary and assessed any condomless anal receptive sex, anal insertive sex and both combined. The fourth measure was a hierarchy of risk practices, ranging from no condomless anal sex, to condomless anal insertive sex only, to condomless anal receptive sex only, to both forms of condomless sex. Measures were taken using 6-month and 30-day recall periods, with the 30-day period being the most recent 30 days when participants completed the questionnaire.
Results
Of the 399 study participants, most identified as non-Black Hispanic (60.4%), with 19.3% identifying as Black and the remainder identifying as mixed race/ethnicity. Fifty-six participants (14.0%) were currently taking PrEP.
Findings for the six binary measures are given in Table 1, with the number reporting the risk behaviour, the percentage of those taking and not taking PrEP who reported the risk behaviour, prevalence ratios, 95% confidence intervals and P-values given. As indicated in Table 1, with only one exception, each measure was clearly significant in support of the study hypothesis. The exception was the 30-day measure of condomless anal receptive sex, with values falling just shy of significance.
Table 1.
Associations between pre-exposure prophylaxis (PrEP) use and condomless anal sex among young men who have sex with men
| Measure of anal sex | Using PrEP (n = 56) | Not using PrEP (n = 343) | PR 95% CI | P-value |
|---|---|---|---|---|
| 6-month measures of sex | ||||
| Any condomless anal receptive | 69.6 (39) | 55.4 (190) | 1.26 (1.07–1.59) | 0.02 |
| Any condomless anal insertive | 78.6 (44) | 52.2 (179) | 1.51 (1.27–1.78) | <0.001 |
| Any condomless anal | 80.4 (45) | 59.2 (202) | 1.36 (1.16–1.59) | 0.002 |
| 30-day measures of sex | ||||
| Any condomless anal receptive | 53.6 (30) | 41.1 (141) | 1.30 (0.99–1.71) | 0.08 |
| Any condomless anal insertive | 71.4 (40) | 41.7 (143) | 1.71 (1.39–2.11) | <0.001 |
| Any condomless anal | 91.1 (51) | 55.1 (189) | 1.65 (1.46–1.87) | <0.001 |
Unless indicated otherwise, data are given as % (n). PR, prevalence ratio; CI, confidence interval
Regarding the fourth measure, results from t-tests (not shown in Table 1) further support the hypothesis. For the 6-month hierarchy of risk, the mean was 3.17 among those taking PrEP versus 2.62 among those not taking PrEP. The t-value was 3.21 (df = 389; p = 0.002). For the 30-day measure the mean was 2.78 among those taking PrEP versus 2.39 among those not taking PrEP. The t-value was 2.15 (df = 358; p = 0.03).
Discussion
Using multiple measures, across two different recall periods, the weight of evidence clearly supports the hypothesis that YMSM of colour taking PrEP are more likely to engage in condomless anal sex. This is particularly important relative to receptive anal sex, because rectal STIs may be more likely to go undiagnosed compared with urethral infections.2
Although this is only a single study from one US city, the clear and rapid spikes in national STI rates among men who have sex with men (MSM) suggest that our findings are emblematic of PrEP-related condom displacement occurring for MSM throughout the US. Prospective studies of high-risk MSM are needed to definitively establish the causal relationships suggested here. This suggests that the lack of evidence-based counselling programs regarding condom use while using PrEP2 is a shortcoming of the movement to end AIDS using this biomedical intervention approach.5 To fully respond to the looming AIDS crisis for YMSM of colour,2 the development and testing of evidence-based condom promotion counselling programs that can be implemented as part of a PrEP-based prevention system should be a national priority.
Acknowledgements
Support for the original research was provided by a grant from the National Institute on Drug Abuse of the National Institutes of Health (U01DA036926). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Footnotes
Conflicts of interest
The authors have no conflicts of interest to declare.
References
- 1.Buchbinder SP, Glidden DV, Liu AY, McMahan V, Guanira JV, Mayer KH, et al. HIV pre exposure prophylaxis in men who have sex with men and transgendered women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis 2014; 14: 468–75. doi: 10.1016/S1473-3099(14)70025-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Office of National AIDS Policy. National HIV/AIDS strategy: updated to 2020. Available online at: https://www.hiv.gov/federal-response/national-hiv-aids-strategy/nhas-update [verified 31 July 2015].
- 3.Crosby R, Warner L. Pending research issues in male condom use promotion. Sex Health 2008; 5: 317–919. doi: 10.1071/SH08080 [DOI] [PubMed] [Google Scholar]
- 4.Curran JW, Crosby RA. Preexposure prophylaxis (PrEP): who will benefit and what are the challenges? Am J Prev Med 2013; 44: S163–6. doi: 10.1016/j.amepre.2012.10.005 [DOI] [PubMed] [Google Scholar]
- 5.Crosby RA, Mena L, Vickers-Smith R. Randomised controlled trial of a brief, clinic-based intervention to promote safer sex among young Black men who have sex with men: implications for pre-exposure prophylaxis-related counselling. Sex Health 2019; 16: 187–91. doi: 10.1071/SH18156 [DOI] [PubMed] [Google Scholar]
- 6.Crosby RA. Dealing with pre-exposure prophylaxis-associated condom migration: changing the paradigm for men who have sex with men. Sex Health 2019; 14: 106–10. doi: 10.1071/SH16128 [DOI] [PubMed] [Google Scholar]
- 7.Liu AY, Cohen SE, Vittinghof E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med 2016; 176: 75–84. doi: 10.1001/jamainternmed.2015.4683 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis 2015; 61: 1601–3. doi: 10.1093/cid/civ778 [DOI] [PMC free article] [PubMed] [Google Scholar]
